Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.23.3
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Sep. 24, 2022
Equity [Abstract]      
Schedule of Common Shares Outstanding  
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended Nine Months Ended
September 30,
2023		 September 24,
2022		 September 30,
2023		 September 24,
2022
(In millions)
Balance, beginning of period 1,614  1,612  1,612  1,207 
Common stock issued in the acquisition of Xilinx —  —  —  429 
Common stock issued under employee equity plans 9  10  14  14 
Common stock repurchases for tax withholding on equity awards (3) (3) (4) (5)
Issuance of common stock upon warrant exercise —  —  1  — 
Repurchases of common stock (5) (7) (8) (33)
Balance, end of period 1,615  1,612  1,615  1,612 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount  
Stock-based Compensation
Stock-based compensation expense recorded in the Condensed Consolidated Statements of Operations was as follows: 
Three Months Ended Nine Months Ended
September 30,
2023		 September 24,
2022		 September 30,
2023		 September 24,
2022
(In millions)
Cost of sales $ 6  $ 8  $ 24  $ 20 
Research and development 260  185  721  478 
Marketing, general and administrative 87  82  265  268 
Total $ 353  $ 275  $ 1,010  $ 766 
 
Stock Repurchased During Period, Shares 5,000 8,000  
Payments for Repurchase of Common Stock   $ 752 $ 3,452